FDA Updates Import Alert List to Include Lagom Nicotine Pouches.

Feb.27

FDA updates "98-06 Import Alert" list, allowing seizure of Lagom nicotine pouches from Belagom AB without physical inspection.

Recently, the United States FDA updated its "Import Alert 98-06" list, also known as the "Red List". The updated guidance from the FDA states that customs officials can now detain tobacco products listed on the red list of this import alert without conducting physical inspections.

The product that was included in the "red list" this time is the nicotine pouch brand Lagom from the Swedish company BELAGOM AB.

The following is the detailed list.

Belagom AB Company

Publication Date: February 25, 2025

Hollandargatan 22, Stockholm, Sweden.

98 - A tobacco product available for consumer consumption.

Publication date: February 25, 2025.

Description: "Lagom" brand offers smokeless tobacco and nicotine delivery products for consumer use.

Also Read:

[1] FDA Implements Stricter Regulations on Unauthorized New Tobacco Products

[2] FDA Updates Import Alert List for Tobacco Products, BAT Velo Included

[3] FDA Strengthens Import Alerts to Address Unauthorized E-Cigarettes Detention

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.